Axon Enterprise, Inc. (NASDAQ:AXON) Receives Average Recommendation of “Moderate Buy” from Brokerages

Axon Enterprise, Inc. (NASDAQ:AXONGet Free Report) has received a consensus recommendation of “Moderate Buy” from the eleven research firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $314.91.

A number of equities research analysts have issued reports on the stock. Morgan Stanley increased their target price on shares of Axon Enterprise from $285.00 to $310.00 and gave the stock an “equal weight” rating in a report on Friday. William Blair reiterated an “outperform” rating on shares of Axon Enterprise in a report on Wednesday, April 24th. The Goldman Sachs Group upped their price target on Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a report on Wednesday, February 28th. JMP Securities lifted their price objective on Axon Enterprise from $250.00 to $285.00 and gave the company a “market outperform” rating in a research note on Tuesday, February 6th. Finally, StockNews.com lowered shares of Axon Enterprise from a “buy” rating to a “hold” rating in a research note on Thursday, March 14th.

Check Out Our Latest Stock Analysis on Axon Enterprise

Axon Enterprise Trading Up 1.6 %

Shares of NASDAQ AXON opened at $313.30 on Thursday. The stock has a fifty day simple moving average of $305.09 and a 200-day simple moving average of $262.90. Axon Enterprise has a twelve month low of $175.37 and a twelve month high of $329.87. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $23.64 billion, a PE ratio of 136.22 and a beta of 0.93.

Axon Enterprise (NASDAQ:AXONGet Free Report) last released its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.29. The company had revenue of $432.14 million during the quarter, compared to the consensus estimate of $418.97 million. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. On average, equities analysts forecast that Axon Enterprise will post 2.44 earnings per share for the current year.

Institutional Trading of Axon Enterprise

Several institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. raised its stake in Axon Enterprise by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 7,930,905 shares of the biotechnology company’s stock worth $2,048,791,000 after acquiring an additional 40,435 shares in the last quarter. Sands Capital Management LLC increased its position in shares of Axon Enterprise by 0.6% during the fourth quarter. Sands Capital Management LLC now owns 2,628,652 shares of the biotechnology company’s stock worth $679,060,000 after purchasing an additional 16,347 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of Axon Enterprise by 3.3% in the 3rd quarter. Wellington Management Group LLP now owns 1,956,022 shares of the biotechnology company’s stock valued at $389,229,000 after purchasing an additional 62,324 shares during the last quarter. Norges Bank acquired a new stake in shares of Axon Enterprise in the 4th quarter valued at about $195,406,000. Finally, Westfield Capital Management Co. LP grew its stake in Axon Enterprise by 5.1% during the 4th quarter. Westfield Capital Management Co. LP now owns 731,721 shares of the biotechnology company’s stock worth $189,025,000 after buying an additional 35,528 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

About Axon Enterprise

(Get Free Report

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Stories

Analyst Recommendations for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.